10/16/2013

Rivaroxaban worked as well as standard treatment for patients with symptomatic venous thromboembolism with a significantly lower rate of major bleeding events. About 4,100 patients each received rivaroxaban or standard therapy, and researchers reported 40 major bleeding incidents with rivaroxaban and 72 with standard treatment.

Related Summaries